|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net earnings (loss) | |||||
| Adjustments to reconcile net earnings (loss) to net cash provided by operating activities | |||||
| Depreciation and amortization | |||||
| Stock compensation expense | |||||
| Impairment | |||||
| (Gain) on debt extinguishment | |||||
| (Gain) on acquisition | |||||
| Deferred income taxes | |||||
| (Gain) loss on divestitures, net | |||||
| Loss on disposal of equipment | |||||
| Other adjustments, net | |||||
| Changes in assets and liabilities | |||||
| Premium and trade receivables | |||||
| Other assets | |||||
| Medical claims liabilities | |||||
| Unearned revenue | |||||
| Accounts payable and accrued expenses | |||||
| Other long-term liabilities | |||||
| Other operating activities, net | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Purchases of investments | |||||
| Sales and maturities of investments | |||||
| Acquisitions, net of cash acquired | |||||
| Divestiture proceeds, net of divested cash | |||||
| Other investing activities, net | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from long-term debt | |||||
| Payments and repurchases of long-term debt | |||||
| Common stock repurchases | |||||
| Proceeds from common stock issuances | |||||
| Payments for debt extinguishment | |||||
| Purchase of noncontrolling interest | |||||
| Debt issuance costs | |||||
| Other financing activities, net | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash and cash equivalents | |||||
| Cash and cash equivalents reclassified (to) from held for sale | |||||
| Cash, cash equivalents and restricted cash and cash equivalents, beginning of period | |||||
| Cash, cash equivalents and restricted cash and cash equivalents, end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Interest paid | |||||
| Income taxes paid, net | |||||
| Equity issued in connection with acquisitions | |||||
| The following table provides a reconciliation of cash, cash equivalents and restricted cash and cash equivalents reported within the Consolidated Balance Sheets to the totals above: | |||||
| Cash and cash equivalents | |||||
| Restricted cash and cash equivalents, included in restricted deposits |
Loading...